These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1849315)

  • 1. A comprehensive immunological analysis in chronic fatigue syndrome.
    Gupta S; Vayuvegula B
    Scand J Immunol; 1991 Mar; 33(3):319-27. PubMed ID: 1849315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological abnormalities in patients with chronic fatigue syndrome.
    Tirelli U; Marotta G; Improta S; Pinto A
    Scand J Immunol; 1994 Dec; 40(6):601-8. PubMed ID: 7997849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
    Front Immunol; 2019; 10():1946. PubMed ID: 31475007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome.
    Patnaik M; Komaroff AL; Conley E; Ojo-Amaize EA; Peter JB
    J Infect Dis; 1995 Nov; 172(5):1364-7. PubMed ID: 7594679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic abnormalities in chronic fatigue syndrome.
    Klimas NG; Salvato FR; Morgan R; Fletcher MA
    J Clin Microbiol; 1990 Jun; 28(6):1403-10. PubMed ID: 2166084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
    Manian FA
    Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
    Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
    Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation.
    Peakman M; Deale A; Field R; Mahalingam M; Wessely S
    Clin Immunol Immunopathol; 1997 Jan; 82(1):83-91. PubMed ID: 9000046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome.
    Chapenko S; Krumina A; Kozireva S; Nora Z; Sultanova A; Viksna L; Murovska M
    J Clin Virol; 2006 Dec; 37 Suppl 1():S47-51. PubMed ID: 17276369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic fatigue syndrome, a case of high anti-HHV-6 antibody titer and one associated with primary hyperaldosteronism].
    Kato Y; Kamijima S; Kashiwagi A; Oguri T
    Nihon Rinsho; 1992 Nov; 50(11):2673-8. PubMed ID: 1337563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital].
    Nishikai M
    Nihon Rinsho; 1992 Nov; 50(11):2641-7. PubMed ID: 1337560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Study of Natural Killer Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis.
    Huth TK; Brenu EW; Ramos S; Nguyen T; Broadley S; Staines D; Marshall-Gradisnik S
    Scand J Immunol; 2016 Jan; 83(1):44-51. PubMed ID: 26381393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus.
    Jones JF
    Rev Infect Dis; 1991; 13 Suppl 1():S26-31. PubMed ID: 1850541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte phenotype and function in the chronic fatigue syndrome.
    Straus SE; Fritz S; Dale JK; Gould B; Strober W
    J Clin Immunol; 1993 Jan; 13(1):30-40. PubMed ID: 8095270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic abnormalities associated with chronic fatigue syndrome.
    Barker E; Fujimura SF; Fadem MB; Landay AL; Levy JA
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S136-41. PubMed ID: 8148441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
    Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
    J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
    Maes M; Bosmans E; Kubera M
    Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.